These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31671338)

  • 1. Leuprolide acetate pseudomenopause therapy as a cause of reversible cerebral vasoconstriction syndrome.
    Yamada H; Kikuchi R; Nakamura A; Miyazaki H
    Clin Neurol Neurosurg; 2019 Dec; 187():105562. PubMed ID: 31671338
    [No Abstract]   [Full Text] [Related]  

  • 2. Lomerizine Improved Bath-related Headache Presenting as Reversible Cerebral Vasoconstriction Syndrome.
    Sawamura M; Ogawa M
    Intern Med; 2023 Aug; 62(16):2445. PubMed ID: 36631090
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible cerebral vasoconstriction syndrome.
    Sampaio Rocha Filho PA; Santos Barbosa J; Melo Correa-Lima AR
    Rev Med Chil; 2010 Aug; 138(8):1000-3. PubMed ID: 21140058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR angiography of reversible cerebral vasoconstriction syndrome.
    Cholet C; Dormont D; Law-Ye B
    Diagn Interv Imaging; 2018 Sep; 99(9):525-526. PubMed ID: 30033143
    [No Abstract]   [Full Text] [Related]  

  • 5. Triptan-induced Reversible Cerebral Vasoconstriction Syndrome Presenting With Thunderclap Headache and Paraparesis.
    Ramineni KK; Jakkani RK; Girgani S; Balani A; Satyanarayan S
    Neurologist; 2018 Sep; 23(5):160-162. PubMed ID: 30169369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible Cerebral Vasoconstriction Syndrome: Perhaps Not So Reversible?
    Howarth H; Mandal AKJ; Boyd E; Missouris CG
    Am J Med; 2020 Aug; 133(8):928-929. PubMed ID: 32001224
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversible cerebral vasoconstriction syndrome associated with hormone therapy for intrauterine insemination.
    Freilinger T; Schmidt C; Duering M; Linn J; Straube A; Peters N
    Cephalalgia; 2010 Sep; 30(9):1127-32. PubMed ID: 20713563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Cerebral Vasoconstriction Syndrome.
    Burton TM; Bushnell CD
    Stroke; 2019 Aug; 50(8):2253-2258. PubMed ID: 31272323
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible cerebral vasoconstriction syndrome 3 months after blood transfusion.
    Braun CN; Hughes RL; Bosque PJ
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):915.e1-5. PubMed ID: 22341667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Reversible Cerebral Vasoconstriction Syndrome Related to Pregnancy.
    Carozza RB; Sarma A; Jordan LC
    Pediatr Neurol; 2023 Aug; 145():54-56. PubMed ID: 37276823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache Complicated by Intracranial Hemorrhage and Posterior Reversible Encephalopathy Syndrome:A Case Report].
    Miki K; Takemoto K; Morishita T; Kouzaki Y; Irie Y; Iwaasa M; Abe H; Inoue T
    No Shinkei Geka; 2018 Dec; 46(12):1111-1115. PubMed ID: 30572309
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome.
    Boitet R; de Gaalon S; Duflos C; Marin G; Mawet J; Burcin C; Roos C; Fiedler U; Bousser MG; Ducros A
    Stroke; 2020 Feb; 51(2):670-673. PubMed ID: 31842705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible cerebral vasoconstriction syndrome associated with subarachnoid hemorrhage triggered by hydroxyzine pamoate.
    Matano F; Murai Y; Adachi K; Koketsu K; Kitamura T; Teramoto A; Okubo S; Katayama Y; Sekine T; Takagi R; Kumita S
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2189-91. PubMed ID: 23769656
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible cerebral vasoconstriction syndrome: an important non-aneurysmal cause of thunderclap headaches and subarachnoid hemorrhage.
    Cox M; Sedora-Román NI; Pukenas B; Kung D; Hurst R
    Intern Emerg Med; 2018 Jan; 13(1):135-136. PubMed ID: 28779450
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible cerebral vasoconstriction syndrome following indomethacin.
    Calic Z; Choong H; Schlaphoff G; Cappelen-Smith C
    Cephalalgia; 2014 Dec; 34(14):1181-6. PubMed ID: 24723675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic Characteristics of Hemorrhagic and Ischemic Phases of Reversible Cerebral Vasoconstriction Syndrome.
    Xing B; Lenck S; Krings T; Hengwei J; Jaigobin CS; Schaafsma JD
    Clin Neuroradiol; 2020 Mar; 30(1):85-89. PubMed ID: 30390096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoidance of steroids in the reversible cerebral vasoconstriction syndrome.
    Mawet J
    Neurology; 2017 Jan; 88(3):224-225. PubMed ID: 27940649
    [No Abstract]   [Full Text] [Related]  

  • 18. Diffuse cerebrovascular dilation: Case report of amezinium metilsulfate-induced reversible cerebral vasoconstriction syndrome.
    Kobayashi M
    Cephalalgia; 2016 Mar; 36(3):289-93. PubMed ID: 26016487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible Cerebral Vasoconstriction Syndrome.
    Sorensen DM
    JAMA Neurol; 2016 Feb; 73(2):232-3. PubMed ID: 26642392
    [No Abstract]   [Full Text] [Related]  

  • 20. Recurrent reversible cerebral vasoconstriction syndrome and antiphospholipid syndrome.
    Sowanou A; Ungureanu A; Aguesse C
    Acta Neurol Belg; 2024 Feb; 124(1):329-334. PubMed ID: 37392321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.